Table 2 HBV-human genome junctions identified after de novo infection

From: Initial sites of hepadnavirus integration into host genome in human hepatocytes and in the woodchuck model of hepatitis B-associated hepatocellular carcinoma

HBV inoculum/ time post infection

Total of virus–host junctions detected (no)

Integrated HBV sequence (nt. position)

Host sequence (bp length)

Chromosome number

Sequence locus

Host sequence (nt. position)

Gene

Total of virus–virus junctions detected (no)

NL01.A

 1 h

4

1720–1603

17

1

q21.1

420–437

ANP32E

0

  

1639–1829

18

7

q22.1

98457063–98457081

S3A-26

 
  

1647–1720

40

10

q21.2

111339527–111339567

ANK3

 
  

1662–1603

48

13

q33.1

102521074 102521122

FGF14

 

 3 h

2

1645–1700

27

14

q32.3

54–27

UI

14

  

1603–1624

204

14

q31.3

86038392–86038596

FLRT2/L2

 

 24 h

4

1246–1390

20

1

p21.3

97732036–97732056

DPYD

3

  

1370–1423

16

7

q36.1

60109931–60109947

RNY-1

 
  

1603–1623

141

8

p23.1

7874512–7874653

L1

 
  

1603–1624

204

14

q31.3

86038392–86038596

FLRT2/L2

 

 3 d

6

1371–1390

244

10

q11.21

42599732–42599976

HSAT-II

3

  

1647–1818

505

11

q13.4

71034849–71034344

L2

 
  

1647–1818

502

11

q13.4

71034849–71034347

L2

 
  

1647–1818

505

11

q13.4

71034849–71034344

L2

 
  

1647–1818

544

11

q13.4

71034849–71034305

L2

 
  

1603–1624

204

14

q31.3

86038392–86038596

FLRT2/L2

 

 1 w

5

1647–1818

268

11

q13.4

71034849–71034581

L2

12

  

1647–1818

496

11

q13.4

71034849–71034353

L2

 
  

1647–1818

254

11

q13.4

71034849–71034595

L2

 
  

1634–1818

302

11

q13.4

71034849–71034547

L2

 
  

1634–1818

502

11

q13.4

71034849–71034347

L2

 

 2 w

10

1603–1664

19

1

q31.3

194161891–194161910

eEF1AP14

7

  

1623–1717

151

2

q31.1

171450967–171450816

Myo3B

 
  

1638–1717

151

2

q31.1

171450967–171450816

Myo3B

 
  

1645–1717

188

2

q31.1

171450967–171450779

Myo3B

 
  

1623–1717

160

2

q31.1

171450967–171450,807

Myo3B

 
  

1622–1717

167

2

q31.1

171450967–171450800

Myo3B

 
  

1638–1717

220

2

q33.1

2000084860–200085080

RNU7–147 P

 
  

1276–1389

59

2

q33.1

200085021–200085080

RNU7–147 P

 
  

1638–1784

44

9

q22.3

99607513–99607557

ZNF782

 
  

1642–1784

57

9

q22.3

99607513–99607570

ZNF782

 

 4 w

11

1634–1717

188

2

q31.1

171450967–171450779

Myo3B

5

  

1633–1717

188

2

q31.1

171450967–171450779

Myo3B

 
  

1633–1717

188

2

q31.1

171450967–171450779

Myo3B

 
  

1634–1717

188

2

q31.1

171450967–171450779

Myo3B

 
  

1645–1784

90

9

q22.33

99607513–99607603

ZNF782

 
  

1645–1784

90

9

q22.33

99607513–99607603

ZNF782

 
  

1645–1784

90

9

q22.33

99607513–99607603

ZNF782

 
  

1645–1784

90

9

q22.33

99607513–99607603

ZNF782

 
  

1645–1784

90

9

q22.33

99607513–99607603

ZNF782

 
  

1645–1784

90

9

q22.33

99607513–99607603

ZNF782

 
  

1668–1808

276

10

q21.3

70434086–70434362

TET1

 

 7 w

3

1634–1826

32

2

q37.1

235357695–235357727

RPS20P12

7

  

1643–1826

35

8

p23.1

96050–96085

AC144568

 
  

1645–1739

60

10

p11.23

28765451–28765521

WAC-AS1

 

NL02.C

 1 h

8

1616–1659

120

11

q25

131410505–131410385

NTM

11

  

1606–1659

125

11

q25

131410505–131410380

NTM

 
  

1606–1659

125

11

q25

131410505–131410380

NTM

 
  

1624–1659

120

11

q25

131410505–131410385

NTM

 
  

1606–1659

113

11

q25

131410505–131410392

NTM

 
  

1606–1659

116

11

q25

131410505–131410389

NTM

 
  

1606–1659

135

11

q25

131410505–131410370

NTM

 
  

1606–1659

151

11

q25

131410505–131410354

NTM

 

 24 h

6

1645–1764

274

15

q11.2

21340909–21341183

L1

0

  

1645–1764

274

15

q11.2

21340909–21341183

L1

 
  

1645–1764

274

15

q11.2

21340909–21341183

L1

 
  

1645–1764

274

15

q11.2

21340909–21341183

L1

 
  

1645–1764

274

15

q11.2

21340909–21341183

L1

 
  

1645–1764

274

15

q11.2

21340909–21341183

L1

 

 3 d

2

1625–1606

215

8

p23.1

7441825–7442040

L1

4

  

1624–1603

189

8

p23.1

7150697–7150886

L1

 

 2 w

2

1716–1780

79

1

p2.1

148552682–148552761

NBPF25P

2

  

1390–1388

208

5

q13.3

76373689–76373809

ZBED3

 

NL03.E

 7 d

1

1641–1778

271

10

q21.3

146–417

S3A-37

2

 2 w

12

1647–1826

33

16

p11.2

34456932–34456965

HSAT-II

1

  

1659–1826

35

16

p11.2

34456932–34456967

HSAT-II

 
  

1646–1826

39

16

p11.2

34456932–34456971

HSAT-II

 
  

1647–1816

34

16

p11.2

34456932–34456966

HSAT-II

 
  

1647–1826

34

16

p11.2

34456932–34456966

HSAT-II

 
  

1647–1826

35

16

p11.2

34456932–34456967

HSAT-II

 
  

1647–1826

34

16

p11.2

34456932–34456966

HSAT-II

 
  

1647–1826

34

16

p11.2

34456932–34456966

HSAT-II

 
  

1647–1826

34

16

p11.2

34456932–34456966

HSAT-II

 
  

1647–1826

34

16

p11.2

34456932–34456966

HSAT-II

 
  

1647–1826

34

16

p11.2

34456932–3445696

HSAT-II

 
  

1647–1826

34

16

p11.2

34456932–34456966

HSAT-II

 
  1. Abbreviations: AC144568, uncharacterized RNA gene; ANK3, ankyrin3; ANP32E, acidic (leucine rich) nuclear phosphoprotein 32 family, member E; DPYD, dihydropyrimidine dehydrogenase; eEF1AP14, eukaryotic elongation factor 1 ribosomal protein; FGF14, fibroblast growth factor 14; FLRT2, fibronectin leucine rich transmembrane protein; HSAT-II, human satellite II DNA; L1, long-interspersed nuclear element-1; L2, long-interspersed nuclear element-2; Myo3B, myosin III B; NTM, neurotrimin; NBPF25P, neuroblastma breakpoint family member 25 pseudogene; RNU7-147P, RNA U7 small nuclear 147 pseudogene; RNY-1, Ro-associated Y pseudogene 1; RPS20P12, ribosomal protein S20 pseudogene 12; S3A-26, ribosomal protein S3A pseudogene 26; S3A-37, ribosomal protein S3A pseudogene 37; TET1, ten-eleven translocation 1 gene; UI, unidentified sequence; WAC-AS1, WAC antisense RNA gene; ZBED3, zinc finger, BED-type containing 3; ZNF782, zinc finger protein 782.